Clinical Trial Update: Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy

View source ↗

Summary

A clinical trial assessing whether quantitative nodal burden can identify ampullary adenocarcinoma patients who will benefit from adjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Adenocarcinoma
• Ampullary Adenoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Ampullary Adenoma, Chemotherapy Effect | Status: RECRUITING